Biosimilars, FDA's breakthrough designation, and oncology strategies were among topics that drew the greatest reader interest this past year. Our latest "Pinkcast" recaps some key stories, traces subsequent developments, and notes key actions to watch for in 2015.
Topics in the latest “Pinkcast” include the development of products to fight the Ebola virus, marketing biosimilars, Astellas's growth in oncology in the U.S., and much more.
For a free trial of "The Pink Sheet", click here: http://www.pharmamedtechbi.com/publications/the-pink-sheet/free-trial?elsca1=pink&elsca2=pinkcast&utm_source=soundcloud&utm_medium=pinkcast
